Renaud, L., Chaillol, I., Galtier, J., Bommier, C., Tessoulin, B., de Colella, J. M. S., Lamy, T., Borel, C., Stamatoullas, A., Gac, A. C., Morschhauser, F., Andre, M., Ghesquieres, H., Traverse-Glehen, A., Casasnovas, O. and Gastine, T. (2020) “Brentuximab vedotin as consolidation treatment in patients with stage I/II Hodgkin’s lymphoma and FDG-PET positivity after 2 cycles of ABVD: final analysis of the BRAPP2 trial”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.301194.